| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/17/2011 | WO2011019023A1 Agent for ameliorating blood-brain barrier disorders |
| 02/17/2011 | WO2011018672A1 Methods and substances for stimulating muscle regeneration |
| 02/17/2011 | WO2011018515A1 Method of purifying pegylated proteins |
| 02/17/2011 | WO2011017915A1 Method for repairing neurodegeneration |
| 02/17/2011 | WO2010138889A8 Peptides for the treatment of hcv infections |
| 02/17/2011 | WO2010129674A3 Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins |
| 02/17/2011 | WO2010123527A3 Use of epidermal growth factor inhibitors in the treatment of viral infection |
| 02/17/2011 | WO2010108177A3 A method and composition using a dual specificity protein tyrosine phosphatase as an antimalarial drug target |
| 02/17/2011 | WO2010099003A3 Compositions and methods for visualizing and eliminating cancer stem cells |
| 02/17/2011 | WO2010096603A3 Cancer-targeting peptides and uses thereof in cancer therapy |
| 02/17/2011 | WO2010087976A3 Anti-cancer protein-platinum conjugates |
| 02/17/2011 | WO2010084169A3 Fgf21 derivatives with albumin binder a-b-c-d-e- and their use |
| 02/17/2011 | WO2005072055A9 Novel brain natriuretic peptide variants and methods of use thereof |
| 02/17/2011 | US20110041194 I-msoi homing endonuclease variants having novel substrate specificity and use thereof |
| 02/17/2011 | US20110041190 Novel chimeric proteins |
| 02/17/2011 | US20110039910 Modulation of apolipoprotein (a) expression |
| 02/17/2011 | US20110039792 Selective Targeting Agents for Mitochondria |
| 02/17/2011 | US20110039791 Acetylcholinesterase (ache)-derived peptide as an inducer of granulocytopoiesis, uses and methods thereof |
| 02/17/2011 | US20110039790 Enhanced ocular neuroprotection and neurostimulation |
| 02/17/2011 | US20110039789 Use of Huntingtin Protein for the Diagnosis and the Treatment of Cancer |
| 02/17/2011 | US20110039788 Compositions, methods and kits for detecting and treating cancer |
| 02/17/2011 | US20110039787 Compositions, kits and methods for treating benign prostate hyperplasia |
| 02/17/2011 | US20110039786 Metastin derivative and use thereof |
| 02/17/2011 | US20110039785 Polypeptide-nucleic acid conjugates and uses thereof |
| 02/17/2011 | US20110039784 Composition for treatment of erectile dysfunction |
| 02/17/2011 | US20110039783 Peptide having hypotensive activity |
| 02/17/2011 | US20110039782 Soybean protein material for patients with renal disease and foods made from the same |
| 02/17/2011 | US20110039781 Treatment of Conditions Related to Cecal Ligation Shock |
| 02/17/2011 | US20110039780 Platelet glycoprotein ib alpha variant fusion polypeptides and methods of use thereof |
| 02/17/2011 | US20110039779 Igf-1r binding proteins and antagonists |
| 02/17/2011 | US20110039778 Peptide Synthesis |
| 02/17/2011 | US20110039777 Cancer treatment using natriuretic peptides |
| 02/17/2011 | US20110039776 Fusion peptide therapeutic compositions |
| 02/17/2011 | US20110039775 Thyroid stimulating hormone fusion proteins |
| 02/17/2011 | US20110039774 Method for repairing neurodegeneration |
| 02/17/2011 | US20110039773 BMP Mutants with Decreased Susceptibility to Noggin |
| 02/17/2011 | US20110039772 Novel uses of vegfxxxb |
| 02/17/2011 | US20110039771 Small humanin-like peptides |
| 02/17/2011 | US20110039770 Inhibitors of protein kinase c isoforms and uses thereof |
| 02/17/2011 | US20110039769 Insulin albumin conjugates |
| 02/17/2011 | US20110039768 Fish protein hydrolysate having a satietogenic activity, nutraceutical and pharmacological compositions comprising such a hydrolysate and method for obtaining same, |
| 02/17/2011 | US20110039767 Food compositions |
| 02/17/2011 | US20110039766 Methods for preventing or treating metabolic syndrome |
| 02/17/2011 | US20110039765 Bioactive Molecules Produced by Probiotic Bacteria |
| 02/17/2011 | US20110039764 Therapeutic composition for bone infectious disease |
| 02/17/2011 | US20110039763 Targeted antimicrobial moieties |
| 02/17/2011 | US20110039762 Targeted antimicrobial moieties |
| 02/17/2011 | US20110039761 Targeted antimicrobial moieties |
| 02/17/2011 | US20110039760 Multimeric forms of antimicrobial peptides |
| 02/17/2011 | US20110039759 Use of Secretin-Receptor Ligands in Treatment of Cystic Fibrosis (CF) and Chronic Obstructive Pulmonary Disease (COPD) |
| 02/17/2011 | US20110039758 Molecular Interactions in Neurons |
| 02/17/2011 | US20110039757 Agonists of Bitter Taste Receptors and Uses Thereof |
| 02/17/2011 | US20110039324 Compositions and methods for enhancing apoptosis |
| 02/17/2011 | US20110039279 Methods and compositions for diagnosing breast cancer |
| 02/17/2011 | US20110038951 Anti-tumor drug, medicament, composition, and use thereof |
| 02/17/2011 | US20110038946 Release of antibiotic from injectable, biodegradable polyurethane scaffolds for enhanced bone fracture healing |
| 02/17/2011 | US20110038938 Compositions for tissue augmentation |
| 02/17/2011 | US20110038924 Osteoarthritis gene therapy |
| 02/17/2011 | US20110038921 Methods and compositions for temporal release of agents from a biodegradable scaffold |
| 02/17/2011 | US20110038917 Therapeutic compositions and methods for treating gram-negative bacterial infections |
| 02/17/2011 | US20110038912 Compositions and methods for delivery of glycopeptide antibiotics to medical device surfaces |
| 02/17/2011 | US20110038903 Apparatus and Process for Generating and Harvesting Adult Stem Cells and Fluid Associated with it from Skin and Omentum for Medical, Cosmetic, and Veterinary Use |
| 02/17/2011 | US20110038899 Pharmaceutical Solutions and Method for Solublilizing Therapeutic Agents |
| 02/17/2011 | US20110038896 Biodegradable immunomodulatory formulations and methods for use thereof |
| 02/17/2011 | US20110038885 Chemokine analogs |
| 02/17/2011 | US20110038882 Methods for Treating Allergic Disease |
| 02/17/2011 | US20110038880 Parasporin-1 receptor and use thereof |
| 02/17/2011 | US20110038872 Methods of diagnosing and treating autism |
| 02/17/2011 | US20110038868 Il-17 homologous polypeptides and therapeutic uses thereof |
| 02/17/2011 | US20110038866 Improved fibronectin-based binding molecules and uses thereof |
| 02/17/2011 | US20110038860 Methods for inhibition of polyclonal b cell activation and immunoglobulin class switching to pathogenic autoantibodies by blocking cd1-mediated interactions |
| 02/17/2011 | US20110038854 Strategy for homo- or hetero-dimerization of various proteins in solution and in cell |
| 02/17/2011 | US20110038853 Use of Kif13A and AP-1 Inhibitors for Inhibiting Melanogenesis |
| 02/17/2011 | US20110038851 Treatment of synucleinopathies |
| 02/17/2011 | US20110038850 G Protein-Coupled Receptor and Modulators Thereof For The Treatment of Gaba-Related Neurological Disorders Including Sleep-Related Disorders |
| 02/17/2011 | US20110038848 Dietary supplement compositions for cardiovascular health |
| 02/17/2011 | US20110038847 Process for preparing bioabsorbable sheet preparation holding thrombin |
| 02/17/2011 | US20110038846 Pharmaceutical composition, use of the pharmaceutical composition for treating a brain tumor, production process thereof and a kit of parts comprising the pharmaceutical composition |
| 02/17/2011 | US20110038845 Diagnosis and treatment for endometriosis |
| 02/17/2011 | US20110038842 High affinity ny-eso t cell receptor |
| 02/17/2011 | US20110038835 Anilides and analogs as rho kinase inhibitors |
| 02/17/2011 | US20110038834 Novel avian cytokines and genetic sequences encoding same |
| 02/17/2011 | US20110038833 Modified fluorinated nucleoside analogues |
| 02/17/2011 | US20110038832 Method for treatment of macular degeneration using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione |
| 02/17/2011 | US20110038831 Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels |
| 02/17/2011 | US20110038830 Cosmetic use of plakoglobin-type proteins |
| 02/17/2011 | US20110038828 Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same |
| 02/17/2011 | US20110038827 Elevation of the plasma hdl-cholesterol level |
| 02/17/2011 | US20110038813 Novel Compositions Against Alkyl-Acyl GPC, The Derivatives And Products Thereof |
| 02/17/2011 | US20110038799 Composition for treatment and improvement of diabetes comprising caveolin as active ingredient and a method for treatment of diabetes using it |
| 02/17/2011 | US20110038791 Methods for inhibiting six1 and eya proteins |
| 02/17/2011 | CA2804755A1 Modified vasoactive intestinal peptides |
| 02/17/2011 | CA2771297A1 Methods of treating cancer using neurotrophin retargeted endopeptidases |
| 02/17/2011 | CA2771289A1 Methods of treating cancer using galanin retargeted endpeptidases |
| 02/17/2011 | CA2771181A1 Methods of treating cancer using growth factor retargeted endopeptidases |
| 02/17/2011 | CA2771164A1 Methods of treating cancer using tachykinin retargeted endopeptidases |
| 02/17/2011 | CA2770822A1 Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels |
| 02/17/2011 | CA2770737A1 Antibodies against human respiratory syncytial virus (rsv) and methods of use |
| 02/17/2011 | CA2770688A1 Methods for preventing or treating metabolic syndrome |
| 02/17/2011 | CA2770334A1 Orally disintegrating compositions of linaclotide |